Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
flatexDEGIRO AG

Start price
Target price
Perf. (%)
€10.85
12.12.23
-
12.12.24
-6.69%
31.01.24

buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.30
11.12.23
-
11.12.24
-0.94%
26.12.23

Could be worthwhile Investment >10% per year
Mind Medicine MindMed Inc.

Start price
Target price
Perf. (%)
€2.95
11.12.23
-
11.12.24
17.54%
23.12.23

Revenue growth >5% per year expected
Medium risks for its business
Future proof or reliable business model
Probably not worthwhile Investment
Northern Data AG

Start price
Target price
Perf. (%)
€28.20
11.12.23
-
11.12.24
-5.32%
20.03.24

High dividend yield expected
positive Cash Flow expected
Normal challenges to pay loans and raise capital
Higher risks for its business
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€14.66
11.12.23
€11.00
11.12.24
39.50%
20.03.24

High dividend yield expected
Small Risks for its business
High valuation
Little Investments for future growth
Coeur Mining Inc.

Start price
Target price
Perf. (%)
€2.77
11.12.23
-
11.12.24
-13.78%
18.01.24

EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Market Leader or Top 3
Very small cyclical dependencies
buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.30
10.12.23
€6.00
31.05.25
-8.68%
04.02.24

Could be very worthwhile Investment >20% year
buy
Genfit S.A.

Start price
Target price
Perf. (%)
€3.32
10.12.23
€4.90
31.05.25
5.43%
17.02.24

Could be very worthwhile Investment >20% year
buy
BioXcel Therapeutics Inc

Start price
Target price
Perf. (%)
€2.91
10.12.23
€3.80
30.06.25
12.65%
17.02.24

Could be very worthwhile Investment >20% year
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€32.80
10.12.23
€55.00
30.06.25
33.54%
24.12.23

Could be very worthwhile Investment >20% year
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.51
10.12.23
-
10.12.24
21.03%
23.12.23

Could be worthwhile Investment >10% per year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.04
10.12.23
-
10.12.24
70.52%
23.12.23

Could be worthwhile Investment >10% per year
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€1.86
10.12.23
-
10.12.24
7.53%
23.12.23

Could be worthwhile Investment >10% per year
buy
Basic Fit NV

Start price
Target price
Perf. (%)
€27.66
09.12.23
-
09.12.24
0.43%
23.12.23

Could be worthwhile Investment >10% per year
buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.97
09.12.23
-
09.12.24
-
11.12.23

Could be very worthwhile Investment >20% year
buy
Amneal Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€6.80
09.12.23
-
09.12.24
-
11.12.23

Could be very worthwhile Investment >20% year
buy
PostNL N.V.

Start price
Target price
Perf. (%)
€1.43
09.12.23
-
09.12.24
-14.69%
18.03.24

buy
Spin Master Corp

Start price
Target price
Perf. (%)
€22.60
08.12.23
-
08.12.24
0.00%
18.03.24

buy
Domo

Start price
Target price
Perf. (%)
€8.88
07.12.23
-
07.12.24
15.99%
15.02.24

buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.22
05.12.23
-
05.12.24
-16.37%
09.12.23

Could be worthwhile Investment >10% per year
buy
Hamborner REIT AG

Start price
Target price
Perf. (%)
€6.62
04.12.23
€9.00
04.12.24
3.93%
05.04.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Brainstorm Cell

Start price
Target price
Perf. (%)
€0.25
02.12.23
€0.40
30.11.25
-29.60%
10.12.23

Could be very worthwhile Investment >20% year
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€30.60
02.12.23
€60.00
28.02.26
7.19%
10.12.23

Could be very worthwhile Investment >20% year
buy
MicroVision Inc

Start price
Target price
Perf. (%)
€2.44
02.12.23
€2.00
02.12.24
-1.29%
05.12.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.18
02.12.23
€0.35
02.12.24
-28.97%
17.02.24

Could be very worthwhile Investment >20% year